Literature DB >> 2256236

Comparison of the mode of action of prostaglandin E2 (PGE2) and sulprostone, a PGE2-derivative, on the lower urinary tract in healthy women. A urodynamic study.

B Schüssler1.   

Abstract

The influence of intravesical administration of PGE2 (1,500 micrograms) and sulprostone, a PGE2 derivative (1,000 micrograms) on urodynamic parameters of the lower urinary tract was tested on six healthy female patients. PGE2 and sulprostone significantly decreased the urethral closure pressure at rest. PGE2 increased the detrusor opening pressure as well as the detrusor pressure during maximum flow. Sulprostone, in contrast, slightly decreased these parameters. Both substances caused a strong urgency sensation resulting in an equally reduced bladder capacity and leading to a measurable bladder instability in both cases. This gives rise to the assumption that frequency, urgency and bladder instability may be the result of intravesical relaxation. By 24 h after administration all urodynamic parameters had returned to pretreatment values, thus indicating that long-term changes in urodynamic parameters are not found after either prostaglandin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2256236     DOI: 10.1007/bf00300786

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  13 in total

1.  Menstrual induction--termination of early pregnancy with a new prostaglandin analogue SHB 286.

Authors:  S M Karim; B Rao; S S Ratnam; R N Prasad; Y M Wong
Journal:  IRCS J Med Sci       Date:  1977-01

2.  Treatment of delayed onset of spontaneous voiding after surgery for incontinence.

Authors:  S L Stanton; L D Cardozo; R Kerr-Wilson
Journal:  Urology       Date:  1979-05       Impact factor: 2.649

3.  The effect on the bladder pressure of sudden entry of fluid into the posterior urethra.

Authors:  J R Sutherst; M Brown
Journal:  Br J Urol       Date:  1978-10

4.  [Comparison of two intramuscular prostaglandin analogs for inducing abortion in the first pregnancy trimester].

Authors:  B Schüssler; K Schmidt-Gollwitzer; M Schmidt-Gollwitzer
Journal:  Gynakol Rundsch       Date:  1980

5.  Is prostaglandin E2 really of therapeutic value for postoperative urinary retention? Results of a prospectively randomized double-blind study.

Authors:  G Wagner; P Husslein; H Enzelsberger
Journal:  Am J Obstet Gynecol       Date:  1985-02-01       Impact factor: 8.661

6.  Improvement in artificial second-trimester abortion with a new tissue-selective prostaglandin E2 derivative.

Authors:  R Schmidt-Gollwitzer; B Schuessler; W Elger; M Schmidt-Gollwitzer
Journal:  Am J Obstet Gynecol       Date:  1980-08-01       Impact factor: 8.661

7.  Clinical and experimental studies on the action of prostaglandins and their synthesis inhibitors on detrusor muscle in vitro and in vivo.

Authors:  M I Bultitude; N H Hills; K E Shuttleworth
Journal:  Br J Urol       Date:  1976

8.  Results in treating 210 patients with detrusor overactivity incontinence of urine.

Authors:  R P Beck; D Arnusch; C King
Journal:  Am J Obstet Gynecol       Date:  1976-07-01       Impact factor: 8.661

9.  The value of intravesical prostaglandin E2 and F2 alpha in women with abnormalities of bladder emptying.

Authors:  K P Delaere; C M Thomas; W A Moonen; F M Debruyne
Journal:  Br J Urol       Date:  1981-08

10.  Effects of prostaglandin E2 applied locally on intravesical and intraurethral pressures in women.

Authors:  K E Andersson; L Henriksson; U Ulmsten
Journal:  Eur Urol       Date:  1978       Impact factor: 20.096

View more
  23 in total

1.  Expression of E-series prostaglandin (EP) receptors and urodynamic effects of an EP4 receptor antagonist on cyclophosphamide-induced overactive bladder in rats.

Authors:  Yao-Chi Chuang; Naoki Yoshimura; Chao-Cheng Huang; Moya Wu; Pradeep Tyagi; Michael B Chancellor
Journal:  BJU Int       Date:  2010-12       Impact factor: 5.588

2.  Stimulation of the pelvic nerve increases bladder capacity in the prostaglandin E2 rat model of overactive bladder.

Authors:  Christopher L Langdale; James A Hokanson; Arun Sridhar; Warren M Grill
Journal:  Am J Physiol Renal Physiol       Date:  2017-06-14

3.  Prostaglandin E2 excitatory effects on rat urinary bladder: a comparison between the β-adrenoceptor modulation of non-voiding activity in vivo and micro-contractile activity in vitro.

Authors:  C Granato; C Korstanje; V Guilloteau; C Rouget; S Palea; J I Gillespie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-06-11       Impact factor: 3.000

Review 4.  Urothelial signaling.

Authors:  Lori Birder; Karl-Erik Andersson
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

5.  Prostaglandin E2 induces spontaneous rhythmic activity in mouse urinary bladder independently of efferent nerves.

Authors:  S Kobayter; J S Young; K L Brain
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

6.  Stimulation of the sensory pudendal nerve increases bladder capacity in the rat.

Authors:  James A Hokanson; Christopher L Langdale; Arun Sridhar; Warren M Grill
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-15

7.  Urinary nerve growth factor correlates with the severity of urgency and pain.

Authors:  Sang Woon Kim; Young Jae Im; Ho Chul Choi; Hyo Jin Kang; Ji Yu Kim; Jang Hwan Kim
Journal:  Int Urogynecol J       Date:  2014-05-28       Impact factor: 2.894

8.  Changes in urinary nerve growth factor and prostaglandin E2 in women with overactive bladder after anticholinergics.

Authors:  Kang Jun Cho; Hyo Sin Kim; Jun Sung Koh; Joon Chul Kim
Journal:  Int Urogynecol J       Date:  2012-06-21       Impact factor: 2.894

9.  Receptors involved in the modulation of guinea pig urinary bladder motility by prostaglandin D2.

Authors:  Na N Guan; Karl Svennersten; Petra J de Verdier; N Peter Wiklund; Lars E Gustafsson
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

10.  Selective α1A-blocker improves bladder storage function in rats via suppression of C-fiber afferent activity.

Authors:  Osamu Yokoyama; Hideaki Ito; Yoshitaka Aoki; Nobuyuki Oyama; Yoshiji Miwa; Hironobu Akino
Journal:  World J Urol       Date:  2009-10-16       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.